Clinical Trial Results:
A 52-WEEK RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED,
MULTICENTRE CLINICAL TRIAL, TO ASSESS THE EFFICACY AND SAFETY OF 200 μg OF THE ANTICHOLINERGIC LAS 34273 COMPARED TO PLACEBO, BOTH ADMINISTERED ONCE DAILY BY INHALATION, IN THE MAINTENANCE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE, STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Summary
|
|
EudraCT number |
2005-005101-39 |
Trial protocol |
DE HU CZ BE GB AT ES DK NL IT |
Global completion date |
06 May 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Jul 2016
|
First version publication date |
17 Jul 2016
|
Other versions |
|
Summary report(s) |
Synopsis_m-34273-30 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.